BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioTie Therapies Corp. 

Tykistokatu 6

Turku    FIN-20520  Finland
Phone: 358-2-274-8900 Fax: 358-2-274-8910


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Clinical Study With BioTie Therapies Corp.''s BTT1023 In Primary Sclerosing Cholangitis Awarded External Grant Funding 7/24/2014 10:37:28 AM
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014 9:16:45 AM
BioTie Therapies Corp. Selects Bracket's CDR Systemâ„¢ For Phase 2 Trial Of Treatment Of Parkinson's Disease 7/16/2014 11:12:27 AM
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014 6:18:03 AM
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014 5:58:45 AM
BioTie Therapies Corp. Awarded $2 Million Grant From The Michael J. Fox Foundation For A Clinical Study With SYN120 In Parkinson's Disease Dementia 7/8/2014 6:12:19 AM
BioTie Therapies Corp.: Tozadenant Phase 2b Parkinson's Disease Study Published In Lancet Neurology 7/8/2014 6:11:09 AM
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/3/2014 9:07:57 AM
BioTie Therapies Corp.: Nepicastat Study In Cocaine Dependence Completes Enrollment Ahead Of Schedule - Top-Line Data Expected Around End 2014 5/27/2014 9:18:25 AM
BioTie Therapies Corp.: Change In The Number Of Votes 5/9/2014 9:48:33 AM
12345678910...